Showing 21 - 40 results of 10,876 for search '(( significant we decrease ) OR ( significant ((changes decrease) OR (larger decrease)) ))', query time: 0.67s Refine Results
  1. 21
  2. 22
  3. 23
  4. 24
  5. 25
  6. 26
  7. 27
  8. 28

    Supplementary Material for: Longitudinal Decrease in Left Ventricular Size with Age: Impact on Mortality and Cardiovascular Hospitalization by figshare admin karger (2628495)

    Published 2025
    “…Results: A decrease in LVEDD was observed in 24% of participants (mean change -9±3 mm) and was significantly associated with older age, female sex, decreased volumes, concentric remodeling and diastolic dysfunction. …”
  9. 29
  10. 30

    Seven forecast scenarios. by Ryan P. Thombs (9138968)

    Published 2025
    “…We find that a decrease in expenditures has a larger effect on decreasing energy consumption than an increase in expenditures does on increasing consumption. …”
  11. 31

    Forecast for each scenario, 2023-2032. by Ryan P. Thombs (9138968)

    Published 2025
    “…We find that a decrease in expenditures has a larger effect on decreasing energy consumption than an increase in expenditures does on increasing consumption. …”
  12. 32
  13. 33
  14. 34

    Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

    Published 2025
    “…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  15. 35

    Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

    Published 2025
    “…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  16. 36
  17. 37
  18. 38
  19. 39
  20. 40

    Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

    Published 2025
    “…While mean respiratory rate was not affected, midazolam resulted in a significant decrease in both VRR (ß = −0.071, 95% CI: −0.120 to −0.021) and VTV (ß = −0.117, 95% CI: −0.170 to −0.062). …”